Replies to post #38126 on Biotech Values

[DewDiligence]

CYTK – Kudos to the analyst from Pacific Growth
Equities (Greg Wade), who confronted management
on today’s CC about the spin.

>>
Wade: “If GSK had not decided not to go forward with the studies you’re proposing, would not the drug have reverted back to you for free anyway?”

CYTK CEO: “I’m not sure it makes sense to get into what could have been instead of what did happen.”
<<

LOL